Ascendis Pharma EBIT 2015-2024 | ASND

Ascendis Pharma EBIT for the quarter ending June 30, 2024 was $-0.144B, a 6.55% decline year-over-year.

  • Ascendis Pharma 2023 EBIT was -0.493B, a 16.71% decline from 2022.
  • Ascendis Pharma 2022 EBIT was -0.592B, a 10.74% increase from 2021.
  • Ascendis Pharma 2021 EBIT was -0.535B, a 41.53% increase from 2020.

EBIT can be defined as earnings before interest and taxes.

Ascendis Pharma EBIT 2015-2024 | ASND

  • Ascendis Pharma 2023 EBIT was -0.493B, a 16.71% decline from 2022.
  • Ascendis Pharma 2022 EBIT was -0.592B, a 10.74% increase from 2021.
  • Ascendis Pharma 2021 EBIT was -0.535B, a 41.53% increase from 2020.

EBIT can be defined as earnings before interest and taxes.